Retension Pharmaceuticals (RTSN) stock

Market cap $119M

$14.24

-6.62%

As of Monday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score RTSN. It is too thinly traded for a fair Quality Score.

Healthcare · Biotech

Follow RTSN's trial news. Pro members can get an alert when Retension Pharmaceuticals files news, and see its trials, share raises, and its CEO's filings.

Get an alert when RTSN files news on its trialSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,191 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

What's next for RTSN

Its trials

A trial underway: Modified Release RTN-001 In Patients With Uncontrolled HypertensionPhase 2 · Recruiting · 280 people · main data estimated Mar 2027 · NCT07142356

For Pro members: 2 filings.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: 1 raise and its amount, and the share count against a year ago.

Insiders

CEO Eric L. Keller bought 20,800 shares on Oct 13. 1 more insider trade this year.

From Form 4: open-market buys and sales only.

Get an alert when Eric Keller buys or sells

For Pro members: every trade, and Eric Keller’s 3 filings and quotes.

Get an alert when RTSN files news on its trialSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 15 daysANDA decisionIn 15 days · ANDA decisionNRXPNRX PharmaceuticalsPreservative-free ketamineNRXPNRX Pharmaceuticals · $104MPreservative-free ketamineA generic, under FDA review (GDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $356MDeramiocelFDA decision due (PDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $933MMolgramostimFDA decision due (PDUFA)

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 168 dates, ranked →

RTSN's latest filings

A change of officers or directors8-K, filed Oct 23
An insider's trade or awardForm 4, filed Oct 22
Prospectus for a sale of securities424B4, filed Oct 9

5 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why RTSN isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. RTSN trades about 200,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.